Is it Useful to Classify PSP and CBD as Different Disorders? Yes-Reference-Cited by-同舟云学术

Is it Useful to Classify PSP and CBD as Different Disorders? Yes

Published:2018-03 Issue:2 Volume:5 Page:145-148
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Ling Helen¹^ORCID,Macerollo Antonella²^ORCID

Affiliation:

1. Queen Square Brain Bank for Neurological Disorders, UCL Institute of NeurologyUniversity College LondonLondon UK

2. Sobell Department of Motor Neuroscience and Movement DisordersUniversity College LondonLondon UK

Funder

CBD Solutions

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mdc3.12581

Reference27 articles.

1. Progressive Supranuclear Palsy

2. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant;Ling H;Neuropathology and applied neurobiology,2013

3. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

4. Clinical Approach to Progressive Supranuclear Palsy

5. Corticodentatonigral Degeneration With Neuronal Achromasia

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review;Neurology and Therapy;2024-05-14

2. Frontotemporal Dementia;Reference Module in Neuroscience and Biobehavioral Psychology;2024

3. Temporal Progression Patterns of White-Matter Degeneration in CBS and PSP Identified with Subtype & Stage Inference (SuStaIn) [Proceedings of the 2021 Young Investigator Award];Japanese Journal of Magnetic Resonance in Medicine;2023-08-15

4. Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?;Antioxidants;2023-08-04

5. A rare case of asymmetric progressive supra nuclear palsy diagnosed In vivo with magnetic resonance/positron emission tomography;Indian Journal of Nuclear Medicine;2023